Re: intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: results from a prospective randomized phase III trial
- PMID: 23312153
- DOI: 10.1016/j.juro.2012.10.103
Re: intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: results from a prospective randomized phase III trial
Comment on
-
Intracutaneous and intravesical immunotherapy with keyhole limpet hemocyanin compared with intravesical mitomycin in patients with non-muscle-invasive bladder cancer: results from a prospective randomized phase III trial.J Clin Oncol. 2012 Jun 20;30(18):2273-9. doi: 10.1200/JCO.2011.39.2936. Epub 2012 May 14. J Clin Oncol. 2012. PMID: 22585689 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
